Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
20 Jun 24 | CAVA CAVA | Common Stock | Grant | Acquire A | No | No | 0 | 1,307 | 0.00 | 16,307 |
13 May 24 | LXRX Lexicon Pharmaceuticals | RSU Common Stock | Grant | Acquire A | No | No | 0 | 36,810 | 0.00 | 36,810 |
13 May 24 | LXRX Lexicon Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 1.79 | 44,906 | 80.38 k | 44,906 |
28 Apr 24 | LXRX Lexicon Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 8,032 | 0.00 | 248,364 |
28 Apr 24 | LXRX Lexicon Pharmaceuticals | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 8,032 | 0.00 | 0 |
17 Nov 23 | CAVA CAVA | Common Stock | Buy | Acquire P | No | No | 33.18 | 10,000 | 331.80 k | 15,000 |
13 Nov 23 | LXRX Lexicon Pharmaceuticals | Common Stock | Buy | Acquire P | No | No | 1.0076 | 200,000 | 201.52 k | 240,332 |